↑ トップへ　← 戻る

 Drug（薬物リスト） DrugBank | All Description Patterns

   e.g. "Sirolimus", "アダリムマブ"

A　B　C　D　E　F　G　H　 I 　J　K　L　M　N　O　P　Q　R　S　T　U　V　W　X　Y　Z　other

118 / 12,170 descriptions found* Show info (disease name, etc.) on mouse-over.
 No.   薬物名（臨床試験情報から抽出）   DrugBank   KEGG DRUG *   KEGG GENES *   KEGG PATHWAY   指定難病告示番号 * 
 1   3% sd-101 dermal cream   -   -   -   -   1件:
36 
 2   6% sd-101 dermal cream   -   -   -   -   1件:
36 
 3   Abh001   -   -   -   -   1件:
36 
 4   Ac-203   -   -   -   -   1件:
36 
 5   Allantoin   Allantoin   D00121   -   -   1件:
36 
 6   Allo-apz2-eb   -   -   -   -   1件:
36 
 7   Allo-asc-dfu   -   -   -   -   1件:
36 
 8   Allogeneic mesenchymal stromal cells   -   -   -   -   1件:
36 
 9   Allogeneic skin-derived abcb5-positive mesenchymal stem cells   -   -   -   -   1件:
36 
 10   Alwextin cream   -   -   -   -   1件:
36 
 11   Anti-thymocyte globulin   -   -   -   -   18件:
11,
13,
14,
36,
40,
41,
42,
45,
46,
49,
51,
60,
62,
65,
164,
283,
284,
285 
 12   Birch bark extract   -   -   -   -   1件:
36 
 13   Blood test   -   -   -   -   5件:
36,
86,
113,
162,
299 
 14   Botulinic toxin   -   -   -   -   1件:
36 
 15   Broccoli   Broccoli   -   -   -   2件:
36,
299 
 16   Busilvex   -   -   -   -   4件:
19,
36,
60,
65 
 17   Busulfan   Busulfan   D00248   -   -   13件:
19,
20,
28,
36,
49,
51,
60,
65,
164,
274,
284,
285,
326 
 18   Calcipotriol   Calcipotriol   D01125   1件: VDR   4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis   1件:
36 
 19   Ccp-020   -   -   -   -   1件:
36 
 20   Ccp-020 (diacerein 1% ointment)   Diacerein   D07270   -   -   1件:
36 
 21   Cell transplantation   -   -   -   -   1件:
36 
 22   Cultured allogeneic fibroblasts   -   -   -   -   1件:
36 
 23   Cx501   Cx501   -   -   -   1件:
36 
 24   Cyclophosphamide   Cyclophosphamide   D00287, D07760   -   -   43件:
13,
14,
16,
19,
20,
26,
28,
35,
36,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
52,
56,
60,
61,
62,
65,
66,
84,
85,
93,
96,
162,
164,
172,
222,
224,
265,
274,
283,
284,
285,
288,
326,
331 
 25   Cyclosporine   Ciclosporin   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   30件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway   33件:
11,
14,
19,
20,
28,
36,
40,
41,
42,
45,
46,
49,
50,
53,
56,
58,
60,
62,
64,
65,
90,
95,
97,
162,
164,
222,
226,
228,
234,
283,
284,
285,
302 
 26   Cyclosporine a   Ciclosporin   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   30件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway   8件:
19,
20,
36,
49,
53,
58,
60,
234 
 27   Células madre mesenquimales haploidénticas derivadas de médula ósea   -   -   -   -   1件:
36 
 28   Diacerein   Diacerein   D07270   -   -   2件:
36,
46 
 29   Diacerein 1% ointment   Diacerein   D07270   -   -   1件:
36 
 30   Diacerein 1% ointment topical formulation   Diacerein   D07270   -   -   1件:
36 
 31   Diacerin cream   -   -   -   -   1件:
36 
 32   Donor mesenchymal stem cell infusions   -   -   -   -   1件:
36 
 33   Dysport   Botulinum toxin type a   D00783   1件: SNAP25   2件: Insulin secretion, Synaptic vesicle cycle   2件:
13,
36 
 34   Eb-101   -   -   -   -   1件:
36 
 35   Episalvan gel   -   -   -   -   1件:
36 
 36   Erythrocine   -   -   -   -   1件:
36 
 37   Erythrocine oral   -   -   -   -   1件:
36 
 38   Erythromycin   Erythromycin   D00140, D00851, D01361, D02009, D02184, D02523, D02524, D02525, D04054   -   -   5件:
6,
36,
164,
228,
291 
 39   Erythromycine   -   -   -   -   1件:
36 
 40   Fibroblasts   -   -   -   -   1件:
36 
 41   Fludarabine   Fludarabine   D01907, D07966   1件: RRM1   5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism   17件:
13,
28,
36,
46,
49,
51,
60,
61,
62,
65,
85,
96,
164,
283,
284,
285,
326 
 42   Fludarabine phosphate   Fludarabine   D01907, D07966   1件: RRM1   5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism   11件:
28,
36,
49,
51,
60,
62,
65,
96,
283,
284,
285 
 43   Gcsf   Filgrastim   D03235   1件: CSF3R   5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer   3件:
36,
65,
284 
 44   Gene-modified autologous fibroblasts   -   -   -   -   1件:
36 
 45   Gentamicin   Gentamicin   D01063, D08013   -   -   3件:
36,
113,
299 
 46   Gentamicin sulfate   Gentamicin   D01063, D08013   -   -   1件:
36 
 47   Gentamicin sulfate, injectable   Gentamicin   D01063, D08013   -   -   1件:
36 
 48   Granulocyte colony stimulating factor   Filgrastim   D03235   1件: CSF3R   5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer   3件:
2,
36,
85 
 49   Granulocyte colony stimulating factor (gcsf)   Filgrastim   D03235   1件: CSF3R   5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer   1件:
36 
 50   Hologene17   -   -   -   -   1件:
36 
 51   Hologene7   -   -   -   -   1件:
36 
 52   Hp802-247   -   -   -   -   1件:
36 
 53   Human dermal fibroblasts cultured on a bioresorbable polyglactin mesh   -   -   -   -   1件:
36 
 54   Human fibroblast-derived dermal substitute, dermagraft   -   -   -   -   1件:
36 
 55   Icx-rhy-013   -   -   -   -   1件:
36 
 56   Isotretinoin   Isotretinoin   D00348   2件: RARA, RARB   8件: Acute myeloid leukemia, Estrogen signaling pathway, Gastric cancer, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer   4件:
36,
39,
159,
160 
 57   Jojoba oil   Jojoba oil   -   -   -   1件:
36 
 58   Jojoba oil with broccoli sprout extract   Jojoba oil   -   -   -   1件:
36 
 59   Lzrse-col7a1 engineered autologous epidermal sheets   -   -   -   -   1件:
36 
 60   Mesenchymal stem cells (mscs)   -   -   -   -   3件:
13,
36,
96 
 61   Mesenchymal stem cells derived from bone marrow (bm-mscs)   -   -   -   -   1件:
36 
 62   Mesenchymal stem cells extracted from bone marrow   -   -   -   -   1件:
36 
 63   Mesenchymal stromal cells   -   -   -   -   6件:
36,
51,
96,
97,
274,
284 
 64   Methoxsalen   Methoxsalen   D00139   -   -   3件:
36,
46,
96 
 65   Morphine   Morphine   D00842, D02271, D08233   1件: OPRM1   3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction   4件:
36,
46,
70,
86 
 66   Morphine sulphate in intrasite gel   Morphine   D00842, D02271, D08233   1件: OPRM1   3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction   1件:
36 
 67   Mycophenolate   Mycophenolic acid   D05096   2件: IMPDH1, IMPDH2   3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   33件:
2,
11,
13,
14,
19,
20,
28,
35,
36,
42,
43,
45,
49,
51,
53,
60,
62,
65,
66,
84,
85,
95,
96,
162,
164,
222,
224,
226,
234,
283,
284,
285,
300 
 68   Mycophenolate mofetil   Mycophenolate mofetil   D00752, D05094, D05095   2件: IMPDH1, IMPDH2   3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism   32件:
2,
11,
13,
14,
19,
20,
28,
35,
36,
42,
43,
45,
49,
51,
53,
60,
62,
65,
66,
85,
95,
96,
162,
164,
222,
224,
226,
234,
283,
284,
285,
300 
 69   Normal saline   -   -   -   -   14件:
6,
17,
22,
36,
46,
49,
60,
94,
96,
211,
226,
276,
296,
299 
 70   Oleogel-s10   -   -   -   -   1件:
36 
 71   On 01910.na   -   -   -   -   1件:
36 
 72   Oral erythromycin   Erythromycin   D00140, D00851, D01361, D02009, D02184, D02523, D02524, D02525, D04054   -   -   1件:
36 
 73   Phosphate   Phosphate ion   -   -   -   29件:
2,
3,
11,
12,
13,
28,
36,
46,
49,
51,
53,
60,
62,
65,
70,
78,
81,
83,
90,
96,
97,
164,
235,
256,
283,
284,
285,
286,
299 
 74   Polyphenon e   -   -   -   -   2件:
13,
36 
 75   Pregabalin   Pregabalin   D02716   4件: CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4   7件: Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy (ARVC), Cardiac muscle contraction, Dilated cardiomyopathy (DCM), Hypertrophic cardiomyopathy (HCM), MAPK signaling pathway, Oxytocin signaling pathway   5件:
13,
36,
46,
70,
298 
 76   Psorcutan-ointment   -   -   -   -   1件:
36 
 77   Ptr-01   -   -   -   -   1件:
36 
 78   Qr-313   -   -   -   -   1件:
36 
 79   Qr-313 gel for topical (cutaneous) administration   -   -   -   -   1件:
36 
 80   Reduced intensity transplant conditioning   -   -   -   -   1件:
36 
 81   Rege pro dressing   -   -   -   -   1件:
36 
 82   Rgn-137   -   -   -   -   1件:
36 
 83   Rigosertib   Rigosertib   D10154   1件: PLK1   4件: Cell cycle, FoxO signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation   1件:
36 
 84   Rigosertib oral capsules / rigosertib oral liquid solution / rigosertib intravenous   Rigosertib   D10154   1件: PLK1   4件: Cell cycle, FoxO signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation   1件:
36 
 85   Rituximab   Rituximab   D02994   1件: MS4A1   1件: Hematopoietic cell lineage   42件:
11,
13,
14,
17,
35,
36,
43,
44,
45,
46,
49,
50,
51,
52,
53,
56,
60,
61,
63,
64,
65,
66,
83,
84,
85,
86,
93,
94,
96,
97,
162,
222,
223,
229,
256,
271,
283,
284,
285,
288,
300,
331 
 86   Ropivacaine   Ropivacaine   D04048, D08490   5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A   3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction   3件:
36,
46,
70 
 87   Sd-101   -   -   -   -   1件:
36 
 88   Sd-101 dermal cream (6%)   -   -   -   -   1件:
36 
 89   Sd-101-6.0 cream   -   -   -   -   1件:
36 
 90   Sericare   -   -   -   -   1件:
36 
 91   Sericare®   -   -   -   -   1件:
36 
 92   Serlopitant   Serlopitant   D09378   1件: TACR1   2件: Calcium signaling pathway, Neuroactive ligand-receptor interaction   1件:
36 
 93   Serlopitant tablet   Serlopitant   D09378   1件: TACR1   2件: Calcium signaling pathway, Neuroactive ligand-receptor interaction   1件:
36 
 94   Simplecare   -   -   -   -   1件:
36 
 95   Sin lv mediated ex vivo transduced autologous fibroblasts expressing codon-optimised col7a1   -   -   -   -   1件:
36 
 96   Sirolimus   Sirolimus   D00753   1件: MTOR   43件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway   30件:
13,
17,
34,
35,
36,
46,
51,
60,
62,
63,
65,
66,
67,
85,
89,
96,
98,
137,
157,
158,
192,
222,
277,
278,
279,
280,
281,
283,
285,
331 
 97   Sirolimus 2%   Sirolimus   D00753   1件: MTOR   43件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway   2件:
36,
192 
 98   Sirolimus, 2%   Sirolimus   D00753   1件: MTOR   43件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway   2件:
36,
192 
 99   Sulfate   Sulfate ion   -   -   -   22件:
2,
6,
11,
13,
26,
34,
36,
46,
49,
60,
61,
64,
66,
79,
86,
96,
222,
226,
265,
296,
297,
299 
 100   Tacrolimus   Tacrolimus   D00107, D08556   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   30件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis (ALS), Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway   29件:
2,
11,
13,
36,
46,
49,
50,
51,
53,
60,
61,
62,
65,
66,
85,
95,
96,
97,
113,
151,
158,
164,
222,
224,
226,
228,
283,
284,
299 
 101   Tc-msc   -   -   -   -   1件:
36 
 102   Tetracyclin   Tetracycline   D00201   -   -   1件:
36 
 103   Thymoglobulin   -   -   -   -   4件:
36,
51,
60,
96 
 104   Thymoglobuline   -   -   -   -   4件:
13,
36,
51,
65 
 105   Thymosin beta 4   -   -   -   -   2件:
36,
53 
 106   Topical bercolagene telserpavec   -   -   -   -   1件:
36 
 107   Topical bpm31510 3.0% cream   -   -   -   -   1件:
36 
 108   Topical opiod   -   -   -   -   1件:
36 
 109   Transduced keratinocytes suspension, containing epidermal stem cells genetically corrected with a col17a1-encoding retroviral vector   -   -   -   -   1件:
36 
 110   Transduced keratinocytes suspension, containing epidermal stem cells genetically corrected with a col7a1-encoding retroviral vector   -   -   -   -   1件:
36 
 111   Transduced keratinocytes suspension, containing epidermal stem cells genetically corrected with a col7a1-encoding retroviral vector, obtained from secondary culture of ex vivo expanded autologous human keratinocytes.   -   -   -   -   1件:
36 
 112   Trimethoprim   Trimethoprim   D00145, D06236   -   -   6件:
36,
44,
49,
60,
85,
299 
 113   Triterpene dry extract from birch cork   -   -   -   -   1件:
36 
 114   Unavailable   -   -   -   -   1件:
36 
 115   Vehicle   -   -   -   -   4件:
6,
36,
160,
192 
 116   Vehicle (0% sd-101)   -   -   -   -   1件:
36 
 117   Vpd-737   -   -   -   -   1件:
36 
 118   Zorblisa   -   -   -   -   1件:
36 

先頭へ